Table 2. Comparison of diabetes complications and mortality by prescription status.

Unknown cause of death refers to those who died outside of the hospital, and other cause of death refers to causes other than those stated.

DKA, diabetic ketoacidosis; GLP-1RA, glucagon-like peptide-1 receptor agonists; SGLT2I, sodium-glucose co-transporter-2 inhibitors

	SGLT2I and/or GLP-1RA		P-value
	Non-users, n (%)	Users, n (%)
	2,076 (75.6)	670 (24.4)
Diabetes-related complications
DKA without coma	65 (3.1)	9 (1.3)	0.76
Chronic kidney disease	144 (6.9)	46 (6.9)	1
Other kidney complication	44 (2.1)	26 (3.9)	0.66
Retinopathy	13 (0.6)	3 (0.5)	0.98
Neuropathy	75 (3.6)	20 (3)	0.9
Peripheral artery disease without gangrene	22 (1.1)	15 (2.2)	0.79
Foot ulcer	39 (1.9)	8 (1.2)	0.89
No complications	1,674 (80.6)	543 (81)	0.84
Mortality
Dead	114 (5.5)	18 (2.7)	0.61
Alive	1,962 (94.5)	652 (97.3)	0.004
Cause of death
COVID-19	35 (30.7)	5 (27.8)	0.89
Sepsis	20 (17.5)	1 (5.6)	0.76
Stroke	15 (13.2)	3 (16.7)	0.87
Cardiovascular	10 (8.8)	3 (16.7)	0.7
Cancer	9 (7.9)	3 (16.7)	0.66
Other	14 (12.3)	0	-
Unknown	11 (9.6)	3 (16.7)	0.72